The new indication could give Novo Nordisk a boost against rivals in the GLP-1 agonist class, including Eli Lilly, whose dual GIP/GLP-1 agonist Mounjaro (tirzepatide) competes in the diabetes category and is in a phase 3 trial (TREASURE-CKD) looking at a CKD indication in people with obesity, with and without diabetes
It is not yet clear whether there may be a subgroup of people with Parkinsons disease who may get benefit from the use of exenatide, Thomas Foltynie , BSc, MBBS, PhD, professor of neurology in the department of clinical and movement neurosciences at the University College London Institute of Neurology, said in a release related to the study
Routine self-monitoring is not universally recommended for all people with type 2 diabetes, but may be advised during medication adjustments, illness, or if you take insulin or medications with hypoglycaemia risk
Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging
Using the Follicular Unit Extraction Technique in Treatment of Male Androgenetic Alopecia
Short answer: No